Dear All,
We have achieved our first approved description for the Grifols Dx division for use at our Diagnostic congresses and tradeshows! Please limit your use to congresses and tradeshow listings.
Please note that this is different than the "about Grifols" company description we have proposed for press release and other potential uses. We will confirm that info separately when a decision is made. This text should be used for all Diagnostic congresses Grifols attends to related to all products in our transfusion medicine portfolio.
Final text for Grifols should read:
Grifols has a history of more than 70 years of commitment to transfusion medicine and patient safety. Our broad range of innovative diagnostic solutions plays a key role in ensuring the availability of safe and compatible blood products in markets worldwide. Active in all the different areas of transfusion safety, we provide products and systems for blood collection, typing, screening and traceability. Today, thousands of blood banks and transfusion services around the world trust in Grifols' diagnostic products.
Please use as appropriate for the types of events described moving forward.
Regards,
Sri